COST Action CA16225 "Realising the therapeutic potential of novel cardioprotective therapies" (External organisation)

  • Maija Dambrova (Delegated representative)

Activity: Membership typesMembership of network

Description

COST Action CA16225 "Realising the therapeutic potential of novel cardioprotective therapies" Representative of Latvia in the Steering Committee
Period19 Oct 201718 Apr 2022
Held atCOST Action CA16225 "Realising the therapeutic potential of novel cardioprotective therapies"
Degree of RecognitionInternational